USWBSI

USWBSI Abstract Viewer

2026 National Fusarium Head Blight Forum


FHB Management (MGMT)

Poster # 102

Can Host Resistance Offset Fungicide Costs for Fusarium Head Blight Management in Wheat?

Authors & Affiliations:

Gabriel de Moraes Chitolina 1 and Carl A. Bradley 1
1. University of Kentucky, Department of Plant Pathology, Princeton, KY
Corresponding Author: Carl Bradley, carl.bradley@uky.edu

Presenting Author:

de Moraes Chitolina, Gabriel
gabriel.chitolina@uky.edu

Abstract:

Fusarium head blight (FHB), caused primarily by Fusarium graminearum, can reduce wheat yield and grain quality and result in contamination with deoxynivalenol (DON). Integrating moderately resistant wheat varieties with fungicides is recommended for FHB management; however, premium fungicides can substantially increase production costs compared with generic tebuconazole products. Field trials were conducted at Princeton, Kentucky, in 2022, 2023, and 2024 to determine whether a moderately resistant variety combined with lower-cost tebuconazole could provide agronomic and economic benefits comparable to premium fungicides and whether a similar strategy would be effective with an FHB-susceptible variety. Susceptible and moderately resistant varieties were treated with tebuconazole (Folicur), Miravis Ace, Prosaro, Prosaro Pro, or Sphaerex, with nontreated controls included. Across years, treatment significantly affected grain yield (P = 0.0088) and DON concentration (P = 0.0001), but not grain moisture or test weight. Yield ranged from 57.8 to 70.2 bu/A, with the greatest yield observed for the moderately resistant variety treated with Miravis Ace. DON ranged from 0.9 to 2.5 ppm, with the greatest concentration in the nontreated susceptible variety and lowest concentration in the moderately resistant variety treated with Miravis Ace. Economic returns were calculated relative to the nontreated susceptible variety and accounted for fungicide costs and grain-price discounts associated with elevated DON, low test weight, and high grain moisture. Net economic benefit differed among treatments (P = 0.0083) and ranged from $25.58/A for the nontreated moderately resistant variety to $113.26/A for the moderately resistant variety treated with Miravis Ace. Tebuconazole provided net economic benefits of $53.81/A and $41.32/A when applied to susceptible and moderately resistant varieties, respectively. These results indicate that lower-cost tebuconazole can provide positive economic returns with either variety class; however, the greatest economic benefit was achieved by combining moderate FHB resistance with a premium fungicide. Fungicide cost alone, therefore, may not be the best predictor of the most profitable FHB management program.


© Copyright 2026 by individual authors. All rights reserved. No part of this abstract or paper publication may be reproduced without prior permission from the applicable author(s).